David Gilboa

Investment Partner , Angel

Overview

Gender
male
Investor Type
Investment Partner,Angel
Investor Stage
Seed

Dave Gilboa is the co-founder and co-CEO of Warby Parker, a transformative lifestyle brand offering designer eyewear at a revolutionary price while leading the way for socially conscious businesses. In 2015, Fast Company named Warby Parker the most innovative company in the world.

Prior to Warby Parker, Dave worked at merchant bank Allen & Company and Bain & Company. Dave has worked extensively with non-profit organizations, and serves as a founding member of the Entrepreneur Board of Venture for America, an organization dedicated to mobilizing graduates as entrepreneurs in low-cost cities. He is a member of the Aspen Institute’s 2014 Henry Crown Fellowship class and the Aspen Global Leadership Network, received the Ernst & Young Entrepreneur of the Year award, and was recognized as part of “The Next Establishment” by Vanity Fair.

Born in Sweden and raised in San Diego, Dave graduated with a BS in Bioengineering with Honors from UC Berkeley and holds an MBA from The Wharton School of the University of Pennsylvania.

With the ultimate goal of making safe, routine vision tests more accessible and convenient for the millions of adults who wear prescription glasses, Warby Parker introduced Prescription Check in 2017, a mobile refraction service designed in-house that, if you are eligible, allows an eye doctor to assess your vision and provide an updated prescription within 24 hours.

Personal Investments

Number of Investments
6
David Gilboa has made 6 investments. Their most recent investment was on Oct 3, 2018, when Rocket Money raised $5M.
Date Company Name Round Money Raised Industry
Jan 25, 2022 Archive Pre-seed $1.33M E-Commerce Detail
Oct 13, 2021 Blank Street Series A $25M Coffee Detail
Sep 12, 2019 Magic Spoon Seed $5.50M Food and Beverage Detail
Apr 30, 2019 Small Door Seed $3.50M Health Care Detail
Oct 3, 2018 Rocket Money Series A $5M Billing Detail
Apr 17, 2018 Parsley Health Series A $10M Health Care Detail